Bioreactor

Bioreactor designates a controlled vessel that supports biological production processes by maintaining optimal conditions for cell growth and product expression. These systems regulate key parameters including temperature, pH, dissolved oxygen, agitation, and nutrient feeding to ensure consistent culture performance and product quality. Bioreactors range from small scale development units to large commercial systems producing high volumes of biologic drug substance.

In biopharmaceutical manufacturing, bioreactors represent the core infrastructure of upstream processing for monoclonal antibodies, recombinant proteins, vaccines, and emerging advanced therapies. Process development teams optimise bioreactor conditions to improve cell viability, increase titres, and maintain critical quality attributes such as glycosylation profiles and product integrity. Single use bioreactors have expanded adoption due to reduced cleaning requirements, faster turnaround, and improved operational flexibility for multi-product facilities. As manufacturers pursue intensified processes and higher productivity, bioreactor technologies continue evolving through improved sensor integration, automation, and advanced control strategies supporting consistent large scale production under GMP requirements.